SCHEMBL3553415

SCHEMBL3553415

NC1c2ccccc2-c2c(-c3nc4cc(C(=O)O)ccc4[nH]3)cccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
RAB9A P51151 3/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 2/20 0.46
NPC1 O15118 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HSP90AB1 P08238 5/20 0.46
KMT2A Q03164 2/20 0.43
POLB P06746 2/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
F2 P00734 1/20 0.40
F9 P00740 1/20 0.40
F10 P00742 1/20 0.40
PLG P00747 1/20 0.40
PLAU P00749 1/20 0.40
PLAT P00750 1/20 0.40
PRSS1 P07477 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3553419 1.00 KDM4E (0.46) KDM4ERAB9AALDH1A1HPGDNPC1
SCHEMBL2312012 0.87 HSP90AB1 (0.45) KDM4ERAB9AALDH1A1HPGDNPC1
SCHEMBL2311273 0.84 HSP90AB1 (0.41) KDM4ERAB9AALDH1A1HPGDNPC1
SCHEMBL2311266 0.84 HSP90AB1 (0.41) KDM4ERAB9AALDH1A1HPGDNPC1
SCHEMBL3550438 0.81 HSP90AB1 (0.44) KDM4ERAB9AALDH1A1HPGDNPC1
SCHEMBL3550435 0.81 HSP90AB1 (0.44) KDM4ERAB9AALDH1A1HPGDNPC1
SCHEMBL2314631 0.80 SCD (0.45) KDM4ERAB9AALDH1A1HPGDNPC1
SCHEMBL2314626 0.80 SCD (0.45) KDM4ERAB9AALDH1A1HPGDNPC1
SCHEMBL2312032 0.80 KDM4E (0.49) KDM4EALDH1A1HPGDHSP90AB1L3MBTL1
SCHEMBL2312038 0.80 KDM4E (0.49) KDM4EALDH1A1HPGDHSP90AB1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7674795-B2 Fluorene derivatives, composition containing said derivatives and the use thereof AVENTIS PHARMA SA (FR) 2010-03-09 US disclosed
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof AVENTIS PHARMA S.A. (FR) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof HSP90B1, HSP90AB1, HSP90AA1 KDM4E 3419/4885RAB9A 1012/4885ALDH1A1 3050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.